CAS 129954-34-3 · Neuro Research
$29.00
Bulk Discount
⚠ RESEARCH USE ONLY
This product is sold strictly for in vitro laboratory research use only. Not for human or animal consumption, diagnostic use, or therapeutic application. Purchasers must be qualified researchers or authorized purchasers for a research institution.
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the endogenous immunomodulatory peptide tuftsin, extended with a stabilizing Pro-Gly-Pro sequence at the C-terminus.
In research models, Selank has been examined for its role in anxiety-related behavior, expression of brain-derived neurotrophic factor (BDNF), enkephalin metabolism, and immune-related cytokine signaling.
Reference: Volkova A. et al. (2016), Front Pharmacol, 7, 31.
Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in Moscow as a more stable analog of tuftsin, a tetrapeptide fragment of immunoglobulin G. Appending the Pro-Gly-Pro tail was designed to slow enzymatic degradation and extend the peptide’s activity in research settings. Since then it has been studied in preclinical and early clinical research, largely in the Russian literature.
Reference: Zozulia A. A. et al. (2008), Zh Nevrol Psikhiatr Im S S Korsakova, 108(4), 38-48.
CAS #: 129954-34-3
Molecular Formula: C33H57N11O9
Molecular Weight: 751.9 g/mol
PubChem CID: 11765600
Selank has been studied in rodent behavioral models and in vitro systems. Reported findings describe effects on neurotransmitter systems, gene expression in the brain, and modulation of immune-related signaling.
Key Areas of Research:
These observations make Selank a frequently cited research tool for studying the interface between neuropeptides, stress-related behavior and immune signaling.
References: Volkova A. et al. (2016), Front Pharmacol, 7, 31.; Filatova E. et al. (2017), Front Pharmacol, 8, 89.
Everything you need to know about our products and processes.
Get the latest on our research peptides
The statements on this website have not been evaluated by the U.S. Food and Drug Administration. The products and information provided by Pride Peptides are not intended to diagnose, treat, cure, or prevent any disease. Pride Peptides LLC is a research chemical supplier. We are not a compounding pharmacy or compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.
© 2026. All rights reserved.